Rebecca L Blanchard

Title: Rebecca L Blanchard: Innovator in Genetic Markers for Clostridium Difficile Treatment

Introduction

Rebecca L Blanchard is a notable inventor based in Allentown, PA (US). She has made significant contributions to the field of genetics, particularly in identifying human genetic markers associated with responses to treatments targeting clostridium difficile toxin B. Her work has the potential to improve patient outcomes in treating diseases susceptible to this toxin.

Latest Patents

Rebecca holds a patent for her invention titled "Human genetic markers associated with response to treatments that target clostridium difficile toxin B." This patent provides valuable genetic markers located on human chromosome 6 that are linked to beneficial responses to treatments targeting toxin B, such as TcdB antibodies. These markers are instrumental in identifying patients who are likely to benefit from such treatments, thereby aiding in selecting the most appropriate therapy. Additionally, her invention encompasses antibodies, drug products, and kits that utilize these TcdB treatment response markers.

Career Highlights

Throughout her career, Rebecca has worked with prominent organizations, including Merck Sharp & Dohme Corporation and Beijing Genomics Institute at Shenzhen. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Rebecca has collaborated with notable colleagues such as Peter M Shaw and Devan V Mehrotra. These partnerships have further enhanced her research and innovation in the field of genetics.

Conclusion

Rebecca L Blanchard is a pioneering inventor whose work in genetic markers for clostridium difficile treatment showcases her commitment to advancing medical science. Her contributions are poised to make a significant impact on patient care and treatment efficacy.